GENinCode (GENI) Competitors GBX 4.15 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitors GENI vs. EDR, DIS, AMC, LION, SPHR, GVC, SONG, NFC, MCS, and TKOShould you be buying GENinCode stock or one of its competitors? The main competitors of GENinCode include Egdon Resources (EDR), Distil (DIS), Amur Minerals (AMC), Lionsgold (LION), Sphere Medical (SPHR), Entain PLC (GVC.L) (GVC), Hipgnosis Songs (SONG), Next Fifteen Communications Group (NFC), McCarthy & Stone (MCS), and Taseko Mines (TKO). These companies are all part of the "entertainment" industry. GENinCode vs. Egdon Resources Distil Amur Minerals Lionsgold Sphere Medical Entain PLC (GVC.L) Hipgnosis Songs Next Fifteen Communications Group McCarthy & Stone Taseko Mines GENinCode (LON:GENI) and Egdon Resources (LON:EDR) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, community ranking, risk, media sentiment and institutional ownership. Does the media favor GENI or EDR? In the previous week, GENinCode's average media sentiment score of 0.00 beat Egdon Resources' score of -1.45 indicating that GENinCode is being referred to more favorably in the media. Company Overall Sentiment GENinCode Neutral Egdon Resources Negative Does the MarketBeat Community believe in GENI or EDR? Egdon Resources received 368 more outperform votes than GENinCode when rated by MarketBeat users. CompanyUnderperformOutperformGENinCodeN/AN/AEgdon ResourcesOutperform Votes36882.51% Underperform Votes7817.49% Which has more volatility and risk, GENI or EDR? GENinCode has a beta of 0.66, meaning that its stock price is 34% less volatile than the S&P 500. Comparatively, Egdon Resources has a beta of -0.25, meaning that its stock price is 125% less volatile than the S&P 500. Is GENI or EDR more profitable? Egdon Resources has a net margin of 31.06% compared to GENinCode's net margin of -228.70%. Egdon Resources' return on equity of 8.26% beat GENinCode's return on equity.Company Net Margins Return on Equity Return on Assets GENinCode-228.70% -156.92% -63.99% Egdon Resources 31.06%8.26%4.22% Do analysts rate GENI or EDR? Given Egdon Resources' higher probable upside, analysts plainly believe Egdon Resources is more favorable than GENinCode.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GENinCode 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AEgdon Resources 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Which has preferable valuation & earnings, GENI or EDR? Egdon Resources has higher revenue and earnings than GENinCode. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGENinCode£2.60M2.82-£5.94M-£0.05-83.00Egdon Resources£8.08M0.00£2.51MN/AN/A Do institutionals & insiders believe in GENI or EDR? 47.6% of GENinCode shares are owned by institutional investors. Comparatively, 18.6% of Egdon Resources shares are owned by institutional investors. 39.8% of GENinCode shares are owned by company insiders. Comparatively, 63.8% of Egdon Resources shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryEgdon Resources beats GENinCode on 9 of the 12 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get GENinCode News Delivered to You Automatically Sign up to receive the latest news and ratings for GENI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GENI vs. The Competition Export to ExcelMetricGENinCodeDiagnostics & Research IndustryMedical SectorLON ExchangeMarket Cap£7.34M£17.51M£5.41B£1.60BDividend YieldN/A6.10%5.15%10.93%P/E Ratio-83.002.18113.591,755.31Price / Sales2.822,474.421,480.95232,682.53Price / Cash0.834.6039.8336.19Price / Book2.082.764.642.88Net Income-£5.94M£59.41M£119.13M£145.32M7 Day Performance1.22%-1.47%0.78%0.11%1 Month Performance-22.07%-7.57%5.66%-0.11%1 Year Performance-46.45%18.67%36.85%15.48% GENinCode Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GENIGENinCodeN/AGBX 4.15flatN/A-46.8%£7.34M£2.60M-83.002,300Gap DownEDREgdon ResourcesN/AGBX 4.40flatN/AN/A£24.88M£8.08M220.0011,000News CoverageDISDistilN/AGBX 0.19-9.5%N/A-52.4%£1.89M£1.52M17.50220,000High Trading VolumeAMCAmur MineralsN/AGBX 0.09flatN/AN/A£1.25MN/A-8.7533,700LIONLionsgoldN/AN/AN/AN/A£0.00N/A0.002,021SPHRSphere MedicalN/AN/AN/AN/A£0.00N/A0.0010,900Gap UpHigh Trading VolumeGVCEntain PLC (GVC.L)N/AGBX 1,039.50+0.6%N/A+0.0%£6.08B£3.40B-38.7913,345SONGHipgnosis SongsN/AGBX 101.80flatN/A+45.0%£1.23B£124.41M-1,131.111NFCNext Fifteen Communications GroupN/AGBX 799-3.0%N/A+0.0%£787.02M£602.53M-974.3912,800Gap UpMCSMcCarthy & StoneN/AGBX 119.80flatN/A+0.0%£644.25M£621.43M21.397,500High Trading VolumeTKOTaseko Mines1.0343 of 5 starsGBX 174.50+1.7%GBX 285+63.3%+95.1%£511.90M£582.21M1,745.00N/A Related Companies and Tools Related Companies EDR Competitors DIS Competitors AMC Competitors LION Competitors SPHR Competitors GVC Competitors SONG Competitors NFC Competitors MCS Competitors TKO Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:GENI) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GENinCode Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share GENinCode With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
